PROTAGONIST THERAPEUTICS INC (PTGX) Institutional Shareholders

PROTAGONIST THERAPEUTICS INC (PTGX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $8.62B in PTGX holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of PTGX tracked by InsiderSet, reporting ownership valued at approximately $1.26B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.56B, representing an estimated gain of +23.53% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 59% of the total disclosed PTGX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Farallon Capital Management Llc, Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in PROTAGONIST THERAPEUTICS INC (PTGX).

This page ranks the largest institutional PTGX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

332

Total Reported Value

$8.62B

Largest Holder

Blackrock, Inc.

Largest Position

$1.26B

Insider Transactions (90d)

7

Latest Filing Quarter

Q2 2026

New Institutional Positions

65

Funds Exiting Positions

0

Page 1 of 7
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.02%10,307,837$1,263,534,678$1,560,812,679+$297,278,001+23.53%
Farallon Capital Management Llc4.36%6,348,906$669,174,692$961,351,347+$292,176,655+43.66%
Rtw Investments, Lp5.31%5,059,053$533,224,186$766,041,805+$232,817,619+43.66%
Vanguard Portfolio Management Llc0.02%3,629,298$444,879,349$549,548,303+$104,668,954+23.53%
Ubs Group Ag0.07%3,399,221$416,676,511$514,710,044+$98,033,533+23.53%
State Street Corp0.01%3,321,554$407,156,089$502,949,707+$95,793,618+23.53%
Wellington Management Group Llp0.07%3,599,644$379,402,479$545,058,094+$165,655,615+43.66%
Vanguard Capital Management Llc0.01%2,853,394$349,769,037$432,060,919+$82,291,882+23.53%
Janus Henderson Group Plc0.15%2,891,527$304,866,424$437,835,018+$132,968,594+43.62%
Johnson & Johnson37.59%2,449,183$300,220,852$370,855,290+$70,634,438+23.53%
Invesco Ltd.0.03%2,164,670$228,156,218$327,774,331+$99,618,113+43.66%
Geode Capital Management, Llc0.01%1,741,209$213,475,772$263,653,867+$50,178,095+23.51%
Citadel Advisors Llc0.12%1,551,900$163,570,260$234,988,698+$71,418,438+43.66%
Woodline Partners Lp0.56%1,414,173$149,053,834$214,134,076+$65,080,242+43.66%
Jennison Associates Llc0.08%1,151,681$141,173,058$174,387,537+$33,214,479+23.53%
Bank Of America Corp0.01%1,295,434$136,538,743$196,154,616+$59,615,873+43.66%
Perceptive Advisors Llc2.57%1,230,879$129,734,647$186,379,698+$56,645,051+43.66%
Morgan Stanley0.01%905,992$111,056,578$137,185,309+$26,128,731+23.53%
Adar1 Capital Management, Llc6.30%994,119$104,780,143$150,529,499+$45,749,356+43.66%
Clearbridge Investments, Llc0.07%725,335$88,911,554$109,830,226+$20,918,672+23.53%
Hood River Capital Management Llc0.88%829,285$87,406,639$125,570,335+$38,163,696+43.66%
Fmr Llc0.00%672,186$82,396,533$101,782,404+$19,385,871+23.53%
Goldman Sachs Group Inc0.01%778,945$82,100,804$117,947,852+$35,847,048+43.66%
Northern Trust Corp0.01%666,105$81,651,153$100,861,619+$19,210,466+23.53%
Driehaus Capital Management Llc0.56%720,928$75,985,811$109,162,918+$33,177,107+43.66%
American Century Companies Inc0.03%598,600$73,376,587$90,640,012+$17,263,425+23.53%
Voya Investment Management Llc0.06%571,618$70,068,935$86,554,398+$16,485,463+23.53%
Pictet Asset Management Holding Sa0.07%567,990$69,624,214$86,005,046+$16,380,832+23.53%
Alyeska Investment Group, L.P.0.18%593,197$62,522,964$89,821,890+$27,298,926+43.66%
Charles Schwab Investment Management Inc0.01%552,956$58,281,562$83,728,598+$25,447,036+43.66%
Vanguard Fiduciary Trust Co0.01%437,747$53,659,027$66,283,651+$12,624,624+23.53%
Principal Financial Group Inc0.02%385,262$47,225,415$58,336,372+$11,110,957+23.53%
Rubric Capital Management Lp0.55%427,998$45,110,989$64,807,457+$19,696,468+43.66%
Bank Of New York Mellon Corp0.01%358,300$43,920,414$54,253,786+$10,333,372+23.53%
683 Capital Management, Llc3.47%355,000$37,417,000$53,754,100+$16,337,100+43.66%
Neuberger Berman Group Llc0.02%302,427$37,071,502$45,793,496+$8,721,994+23.53%
Bnp Paribas Financial Markets0.02%301,472$36,954,438$45,648,890+$8,694,452+23.53%
Nuveen, Llc0.01%284,085$34,823,140$43,016,151+$8,193,011+23.53%
Stephens Investment Management Group Llc0.37%281,832$34,546,967$42,675,001+$8,128,034+23.53%
Vestal Point Capital, Lp0.96%326,159$34,377,159$49,386,996+$15,009,837+43.66%
Bnp Paribas Asset Management Holding S.A.0.03%259,972$31,867,368$39,364,960+$7,497,592+23.53%
Eagle Health Investments Lp5.05%248,322$30,439,311$37,600,917+$7,161,606+23.53%
Adage Capital Partners Gp, L.L.C.0.05%282,436$29,768,754$42,766,459+$12,997,705+43.66%
Segall Bryant & Hamill, Llc0.31%214,724$26,320,868$32,513,508+$6,192,640+23.53%
Seb Asset Management Ab0.10%209,963$25,737,215$31,792,597+$6,055,382+23.53%
Public Sector Pension Investment Board0.07%207,688$25,458,395$31,448,117+$5,989,722+23.53%
Citigroup Inc0.01%198,668$24,352,723$30,082,309+$5,729,586+23.53%
Nextbio Capital Management Lp11.24%229,619$24,201,843$34,768,909+$10,567,066+43.66%
Jpmorgan Chase & Co0.00%183,098$22,569,540$27,724,699+$5,155,159+22.84%
Holocene Advisors, Lp0.05%209,916$22,125,146$31,785,481+$9,660,335+43.66%

Frequently asked questions about PTGX

  • Who owns the most PTGX stock?

    The largest holders of PTGX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PROTAGONIST THERAPEUTICS INC (PTGX).

  • Is PTGX widely held by superinvestors?

    Many widely followed stocks like PTGX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PTGX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.